Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121808224 | 12180822 | 4 | F | 201601 | 20160707 | 20160315 | 20160708 | PER | US-PFIZER INC-2016117705 | PFIZER | 75.00 | YR | F | Y | 65.00000 | KG | 20160708 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121808224 | 12180822 | 1 | PS | TIKOSYN | DOFETILIDE | 1 | Oral | 250 UG, 2X/DAY | 20931 | 250 | UG | CAPSULE, HARD | BID | ||||||
| 121808224 | 12180822 | 2 | SS | TIKOSYN | DOFETILIDE | 1 | 20931 | CAPSULE, HARD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121808224 | 12180822 | 1 | Atrial fibrillation |
| 121808224 | 12180822 | 2 | Atrial flutter |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121808224 | 12180822 | Blood potassium decreased | |
| 121808224 | 12180822 | Drug ineffective | |
| 121808224 | 12180822 | Intentional product misuse | |
| 121808224 | 12180822 | Sinusitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121808224 | 12180822 | 1 | 20140428 | 0 |